QC
MGNX icon

Quadrature Capital’s MacroGenics MGNX Stock Holding History

Quadrature Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.3K Sell
32,629
-232,836
-88% -$497K ﹤0.01% 1231
2025
Q4 		$427K Buy
265,465
+222,751
+521% +$350K ﹤0.01% 735
2025
Q3 		$71.8K Buy
42,714
+21,609
+102% +$35K ﹤0.01% 921
2025
Q2 		$25.7K Buy
+21,105
New +$30.6K ﹤0.01% 988

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Quadrature Capital's MGNX Position: Q1 2026 in Review

Quadrature Capital reduced its MacroGenics (MGNX) stake by 88% in Q1 2026, selling an estimated $497K and leaving 32,629 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Quadrature Capital first reported a position in MGNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $427K in Q4 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Quadrature Capital held 32,629 shares of MacroGenics worth $94.3K as of Q1 2026.
  • Quadrature Capital sold 232,836 MacroGenics shares in Q1 2026, an estimated $497K.
  • MacroGenics made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1231 holding.
  • Quadrature Capital first reported a position in MacroGenics in Q2 2025 and has held it in 4 quarters since.
  • Quadrature Capital's MacroGenics position peaked at $427K in Q4 2025.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.